The relative clinical efficacy and safety of evolocumab, as well as its reduction of low-density lipoprotein cholesterol (LDL-C), are consistent across chronic kidney disease (CKD) groups, according to a study. Moreover, patients with more advanced CKD have higher absolute reduction in the composite of cardiovascular death, myocardial infarction (MI) or stroke with evolocumab.
Physical strain at work appears to take a toll on the health of men, such that those with physically strenuous occupations late in their career are at higher risk of death from cardiovascular diseases (CVDs) and external causes than those doing physically light work, as suggested in a recent study.
Initial treatment with endovascular therapy results in better amputation-free survival in patients with critical limb ischaemia compared with open surgical bypass, according to a study presented at the American Heart Association Scientific Session 2018 (AHA 2018), held in Chicago, Illinois.
Coronary artery disease is prevalent among patients who have undergone coronary angiography, according to a new Philippine study presented at the recently concluded 2019 Congress of the Asian Pacific Society of Cardiology (APSC 2019). However, the obtained rates remain lower than that in other Asian countries.